Amgen Inc. (AMGN)
Total Valuation
Amgen has a market cap or net worth of $153.43 billion. The enterprise value is $207.10 billion.
Market Cap | 153.43B |
Enterprise Value | 207.10B |
Important Dates
The next estimated earnings date is Thursday, April 25, 2024, after market close.
Earnings Date | Apr 25, 2024 |
Ex-Dividend Date | May 16, 2024 |
Share Statistics
Amgen has 535.92 million shares outstanding. The number of shares has decreased by -0.55% in one year.
Shares Outstanding | 535.92M |
Shares Change (YoY) | -0.55% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.25% |
Owned by Institutions (%) | 80.90% |
Float | 534.35M |
Valuation Ratios
The trailing PE ratio is 22.76 and the forward PE ratio is 14.26. Amgen's PEG ratio is 2.56.
PE Ratio | 22.76 |
Forward PE | 14.26 |
PS Ratio | 5.44 |
Forward PS | 4.54 |
PB Ratio | 24.62 |
P/FCF Ratio | 20.85 |
PEG Ratio | 2.56 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.99, with an EV/FCF ratio of 28.14.
EV / Earnings | 30.83 |
EV / Sales | 7.35 |
EV / EBITDA | 13.99 |
EV / EBIT | 19.30 |
EV / FCF | 28.14 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 10.37.
Current Ratio | 1.65 |
Quick Ratio | 0.99 |
Debt / Equity | 10.37 |
Debt / EBITDA | 4.37 |
Debt / FCF | 8.78 |
Interest Coverage | 3.73 |
Financial Efficiency
Return on equity (ROE) is 103.30% and return on invested capital (ROIC) is 9.53%.
Return on Equity (ROE) | 103.30% |
Return on Assets (ROA) | 7.30% |
Return on Capital (ROIC) | 9.53% |
Revenue Per Employee | $1.06M |
Profits Per Employee | $251,573 |
Employee Count | 26,700 |
Asset Turnover | 0.31 |
Inventory Turnover | 1.17 |
Taxes
In the past 12 months, Amgen has paid $1.14 billion in taxes.
Income Tax | 1.14B |
Effective Tax Rate | 14.49% |
Stock Price Statistics
The stock price has increased by +19.22% in the last 52 weeks. The beta is 0.58, so Amgen's price volatility has been lower than the market average.
Beta (1Y) | 0.58 |
52-Week Price Change | +19.22% |
50-Day Moving Average | 290.10 |
200-Day Moving Average | 268.32 |
Relative Strength Index (RSI) | 55.59 |
Average Volume (30 Days) | 3,032,721 |
Short Selling Information
The latest short interest is 11.11 million, so 2.07% of the outstanding shares have been sold short.
Short Interest | 11.11M |
Short Previous Month | 11.02M |
Short % of Shares Out | 2.07% |
Short % of Float | 2.08% |
Short Ratio (days to cover) | 3.52 |
Income Statement
In the last 12 months, Amgen had revenue of $28.19 billion and earned $6.72 billion in profits. Earnings per share was $12.49.
Revenue | 28.19B |
Gross Profit | 19.74B |
Operating Income | 7.90B |
Pretax Income | 7.86B |
Net Income | 6.72B |
EBITDA | 14.80B |
EBIT | 10.73B |
Earnings Per Share (EPS) | $12.49 |
Balance Sheet
The company has $10.94 billion in cash and $64.61 billion in debt, giving a net cash position of -$53.67 billion or -$100.14 per share.
Cash & Cash Equivalents | 10.94B |
Total Debt | 64.61B |
Net Cash | -53.67B |
Net Cash Per Share | -$100.14 |
Equity / Book Value | 6.23B |
Book Value Per Share | 11.63 |
Working Capital | 11.94B |
Cash Flow
In the last 12 months, operating cash flow was $8.47 billion and capital expenditures -$1.11 billion, giving a free cash flow of $7.36 billion.
Operating Cash Flow | 8.47B |
Capital Expenditures | -1.11B |
Free Cash Flow | 7.36B |
FCF Per Share | $13.76 |
Margins
Gross margin is 70.02%, with operating and profit margins of 28.01% and 23.83%.
Gross Margin | 70.02% |
Operating Margin | 28.01% |
Pretax Margin | 27.86% |
Profit Margin | 23.83% |
EBITDA Margin | 52.50% |
EBIT Margin | 38.06% |
FCF Margin | 26.11% |
Dividends & Yields
This stock pays an annual dividend of $9.00, which amounts to a dividend yield of 3.17%.
Dividend Per Share | $9.00 |
Dividend Yield | 3.17% |
Dividend Growth (YoY) | 7.62% |
Years of Dividend Growth | 13 |
Payout Ratio | 72.06% |
Buyback Yield | 0.55% |
Shareholder Yield | 3.70% |
Earnings Yield | 4.38% |
FCF Yield | 4.80% |
Analyst Forecast
The average price target for Amgen is $292.95, which is 3.04% higher than the current price. The consensus rating is "Buy".
Price Target | $292.95 |
Price Target Difference | 3.04% |
Analyst Consensus | Buy |
Analyst Count | 20 |
Revenue Growth Forecast (5Y) | 4.39% |
EPS Growth Forecast (5Y) | 12.58% |
Stock Splits
The last stock split was on November 22, 1999. It was a forward split with a ratio of 2:1.
Last Split Date | Nov 22, 1999 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Amgen has an Altman Z-Score of 1.43 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.43 |
Piotroski F-Score | 6 |